287 related articles for article (PubMed ID: 18154539)
1. Prevalence of extended-spectrum beta-lactamases in South America.
Villegas MV; Kattan JN; Quinteros MG; Casellas JM
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():154-8. PubMed ID: 18154539
[TBL] [Abstract][Full Text] [Related]
2. Characteristics, epidemiology and clinical importance of emerging strains of Gram-negative bacilli producing extended-spectrum beta-lactamases.
Shah AA; Hasan F; Ahmed S; Hameed A
Res Microbiol; 2004; 155(6):409-21. PubMed ID: 15249058
[TBL] [Abstract][Full Text] [Related]
3. Minor extended-spectrum beta-lactamases.
Naas T; Poirel L; Nordmann P
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():42-52. PubMed ID: 18154527
[TBL] [Abstract][Full Text] [Related]
4. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
Gür D; Gülay Z; Akan OA; Aktaş Z; Kayacan CB; Cakici O; Eraç B; Gültekin M; Oğünç D; Söyletir G; Unal N; Uysal S
Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
[TBL] [Abstract][Full Text] [Related]
5. Multidrug resistance in Gram-negative bacteria that produce extended-spectrum beta-lactamases (ESBLs).
Giamarellou H
Clin Microbiol Infect; 2005 Jul; 11 Suppl 4():1-16. PubMed ID: 15953019
[TBL] [Abstract][Full Text] [Related]
6. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat.
Bradford PA
Clin Microbiol Rev; 2001 Oct; 14(4):933-51, table of contents. PubMed ID: 11585791
[TBL] [Abstract][Full Text] [Related]
7. [Clinically important beta-lactamases of gram-negative bacteria: extended-spectrum beta-lactamases (ESBL)].
Hrabák J
Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):103-11. PubMed ID: 17900058
[TBL] [Abstract][Full Text] [Related]
8. Risks of extended-spectrum beta-lactamases.
BMJ Group
Drug Ther Bull; 2008 Mar; 46(3):21-4. PubMed ID: 18337463
[TBL] [Abstract][Full Text] [Related]
9. Extended-spectrum beta-lactamases in North America, 1987-2006.
Bush K
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():134-43. PubMed ID: 18154537
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of co-expression of newer beta-lactamases (ESBLs, Amp-C-beta-lactamases, and metallo-beta-lactamases) in gram-negative bacilli.
Chatterjee SS; Karmacharya R; Madhup SK; Gautam V; Das A; Ray P
Indian J Med Microbiol; 2010; 28(3):267-8. PubMed ID: 20644325
[No Abstract] [Full Text] [Related]
11. Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe.
Cantón R; Novais A; Valverde A; Machado E; Peixe L; Baquero F; Coque TM
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():144-53. PubMed ID: 18154538
[TBL] [Abstract][Full Text] [Related]
12. Increasing extended-spectrum beta-lactamase production and quinolone resistance among Gram-negative bacilli causing intra-abdominal infections in the Asia/Pacific region: data from the Smart Study 2002-2006.
Ko WC; Hsueh PR
J Infect; 2009 Aug; 59(2):95-103. PubMed ID: 19564044
[TBL] [Abstract][Full Text] [Related]
13. Genetic support of extended-spectrum beta-lactamases.
Poirel L; Naas T; Nordmann P
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():75-81. PubMed ID: 18154530
[TBL] [Abstract][Full Text] [Related]
14. Defining an extended-spectrum beta-lactamase.
Livermore DM
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():3-10. PubMed ID: 18154524
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and clonality of extended-spectrum beta-lactamases in Asia.
Hawkey PM
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():159-65. PubMed ID: 18154540
[TBL] [Abstract][Full Text] [Related]
16. New definitions of extended-spectrum β-lactamase conferring worldwide emerging antibiotic resistance.
Lee JH; Bae IK; Lee SH
Med Res Rev; 2012 Jan; 32(1):216-32. PubMed ID: 20577973
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of infections caused by multiresistant gram-negatives: ESBLs, MBLs, panresistant strains.
Rossolini GM; Mantengoli E; Docquier JD; Musmanno RA; Coratza G
New Microbiol; 2007 Jul; 30(3):332-9. PubMed ID: 17802921
[TBL] [Abstract][Full Text] [Related]
18. [Broad-spectrum beta-lactamases in Gram-negative bacteria].
Sundsfjord A; Simonsen GS; Haldorsen B; Lundblad EW; Samuelsen O
Tidsskr Nor Laegeforen; 2008 Dec; 128(23):2741-5. PubMed ID: 19079424
[TBL] [Abstract][Full Text] [Related]
19. Emergence of extended spectrum beta lactamase mediated resistance in neonatal septicemia.
Vinodkumar CS; Neelagund YF
Indian J Pathol Microbiol; 2006 Oct; 49(4):616-9. PubMed ID: 17183878
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of multidrug-resistant gram-negative bacilli producing extended-spectrum β-lactamases (ESBLs) and ESBL genes in solid organ transplant recipients.
Men TY; Wang JN; Li H; Gu Y; Xing TH; Peng ZH; Zhong L
Transpl Infect Dis; 2013 Feb; 15(1):14-21. PubMed ID: 23013385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
